Gritstone company has been working on a next-generation COVID vaccine since 2021 when it partnered with the National Institutes of Health . The company aims to build a shot capable of generating both B cell and T cell immunity potentially translating to broader protection. The vaccine is designed to be selfamplifying meaning it spurs cells to create multiple copies of the encoded antigen RNA